logo

For the Inventor, By the Inventor

Rochester, NY, United States of America

Vassil S Georgiev

This inventor holds 41 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Pennwalt Corporation, Fisons Ltd., Pennwalt Corportion. Active years: 1985-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vassil S Georgiev. Retrieved from https://idiyas.com/inventor/vassil-s-georgiev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41

% Patents Active = 97.6

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 95(Granted Patents)


Location History:

  • Rochester, NY (US) (1985 - 1989)
  • Penfield, NY (US) (1988 - 1989)
  • Gaithersburg, MD (US) (2002 - 2007)

Company Filing History:

goldMedal35 out of 615 
 
Pennwalt Corporation
 patents
silverMedal1 out of 313 
 
Fisons Ltd.
 patents
bronzeMedal1 out of 1 
 
Pennwalt Corportion
 patent
4. 1 out of 1,829 
 
Schering Corporation
 patents
5. 1 out of 1 
 
Vassil Stefanov Georgiev
 patent
6. 2 out of 834,513 
Other
 patents

Years Active: 1985-2007

Loading Chart...
Areas of Expertise:
Viral Infections
Anti-Allergy Treatment
Ketonitrone Derivatives
Spiro Compounds
Adamantane Derivatives
Dihydro Compounds
Phenyl Cyclopropyl
Thiazoloquinazoline
Oxazinone Derivatives
Imidazole Derivatives
Furancarboxamides
Tricyclo Compounds
41 patents (USPTO):Explore Patents
1. 7192606 - Drugs for treating viral infections (2007-03-20),
2. 6596771 - Drugs for treating viral infections (2003-07-22),
3. 6433016 - Drugs for treating viral infections (2002-08-13),
4. 4871862 - .alpha.-Substituted ketonitrone derivatives (1989-10-03),
5. 4845122 - Anti-allergy treatment using 2-(substituted (1989-07-04),
6. 4835283 - 3,5-diphenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]- (1989-05-30),
7. 4831154 - 5-alkyl(or (1989-05-16),
8. 4785117 - 5,5-disubstituted-3-phenyl-3-phenyl-3-[(1H-imidazol-1-ylmethyl) or (1988-11-15),
9. 4777264 - 5-carbonyl derivatives of (1988-10-11),
10. 4777263 - 5-substituted-3-(2-naphthalenyl)-3-((1H-imidazol-1-ylmethyl) or (1988-10-11),
11. 4777262 - 5-(substituted (1988-10-11),
12. 4774334 - Furancarboxamides (1988-09-27),
13. 4769471 - Substituted (1988-09-06),
14. 4769470 - 5-(phenyl or (1988-09-06),
15. 4769469 - 5-(phenyl or (1988-09-06),

Title: Innovator Spotlight: Vassil S Georgiev - Pioneering Antiviral Drug Development in Rochester, NY

Introduction: Vassil S Georgiev, a prolific inventor based in Rochester, NY, has made a significant impact in the field of antiviral drug development with a remarkable 41 patents to his name.

Latest Patents: Georgiev's latest patents showcase his expertise in developing drugs for treating viral infections, focusing on imidodisulfamide derivatives encapsulated in liposomes. These innovative compounds are particularly effective in combating antiviral infections, notably those caused by orthopox viruses.

Career Highlights: Throughout his career, Vassil S Georgiev has worked with renowned companies such as Pennwalt Corporation, where he honed his skills and made groundbreaking contributions to the pharmaceutical industry. His dedication to advancing antiviral therapies has earned him recognition as a trailblazer in his field.

Collaborations: Collaborating with esteemed professionals like George B Mullen and Clyde R Kinsolving, Georgiev has been able to synergize his expertise and experience to drive innovation in antiviral drug discovery. These fruitful collaborations have led to the development of cutting-edge solutions with far-reaching benefits.

Conclusion: Vassil S Georgiev's relentless pursuit of excellence and his passion for revolutionizing antiviral drug development have established him as a leading figure in the scientific community. His patents stand as a testament to his ingenuity and unwavering commitment to advancing healthcare through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…